Baxter reports fourth-quarter and full-year 2023 results

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global medtech leader, today reported results for the fourth quarter and full year ended dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024. “baxter's performance in 2023 reflects our building momentum as we executed upon several strategic initiatives designed to enhance our future performance, including the implementation of a new operating model, the sale of our biopharma solutions b.
BAX Ratings Summary
BAX Quant Ranking